| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.2M | -54.2% |
| Cost of Revenue | $6.8M | -26.5% |
| Gross Profit | $345K | -94.6% |
| R&D Expense | $12.5M | -27.2% |
| SG&A Expense | $17.1M | -20.5% |
| Operating Income | -$34.6M | +12.9% |
| Interest Expense | $9.6M | +130.6% |
| Pre-tax Income | -$38.0M | +15.2% |
| Net Income | -$38.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $5.2M | +52.3% |
| Inventory | $9.8M | +349.2% |
| Current Assets | $47.5M | +101.3% |
| Total Assets | $109.6M | +18.9% |
| Current Liabilities | $50.6M | +40.7% |
| Long-term Debt | $300K | — |
| Total Liabilities | $73.7M | +56.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.5M | +1.6% |
| Capital Expenditures | $1.6M | +675.4% |
| Investing Cash Flow | -$1.7M | -422.9% |
| Financing Cash Flow | $50.2M | +167.9% |
| Free Cash Flow | -$35.1M | -2.6% |
| +15.2% |
| EPS (Basic) | -$0.61 | +30.7% |
| EPS (Diluted) | -$0.61 | +30.7% |
| Stockholders' Equity |
| $16.6M |
| -50.0% |